Napolitano, A., Ballman, K. V., Agulnik, M., Pollack, S. M., D'Angelo, S. P. (2026). SARC045: A phase 2 trial of tebentafusp in HLA-A*02:01–positive patients with advanced clear cell sarcoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps11591